信息搜索
信息关键字：药
  
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]

·股票行情快报：富祥药业（300497）2月8日主力资金净买入764.13万元2023-2-8 21:35:50
·股票行情快报：京新药业（002020）2月8日主力资金净卖出906.91万元2023-2-8 21:14:01
·股票行情快报：亿帆医药（002019）2月8日主力资金净买入212.01万元2023-2-8 21:10:25
·柳药集团：2022年营收预增约11.42%净利预增约22.79%2023-2-8 19:00:15
·国药现代：子公司注射用头孢美唑钠通过仿制药一致性评价2023-2-8 16:09:38
·康弘药业（002773）2月7日主力资金净卖出1505.18万元2023-2-8 11:24:23
·内卷加剧热度降温新冠口服药还有突围机会吗？2023-2-8 11:06:35
·感染人数下降仍在研发的新冠药管线该怎么办？2023-2-8 9:13:36
·今年以来 80家药企接受机构调研2023-2-8 7:08:44
·广济药业：拟4.68亿元参与四公司合并破产重整2023-2-7 22:35:30
·利欣制药拟向盈科瑞购买“1类新药（中药单体）原料及吸入溶液”51%的产权交易作价为2550万2023-2-7 20:45:20
·德源药业2022年预计净利1.1亿-1.25亿同比增长41%-60%在售产品销量稳步增长2023-2-7 20:36:46
·康跃科技资产脱胎换骨：拟更名为长药控股将持续聚焦医药主业2023-2-7 20:02:22
·德源药业2022年业绩预告：净利润同比增长41.22%～60.48%2023-2-7 18:58:26
·长春高新：控股子公司水溶性黄体酮注射液获得药物临床试验批准2023-2-7 16:43:48
·药石科技（300725）2月6日主力资金净卖出2391.44万元2023-2-7 11:53:29
·康跃科技更名长药控股亏损资产完成剥离聚焦医药制造2023-2-7 11:22:43
·马云身影“闪现”！知名机构抛售这只医药股背后大佬众多曾布局多只牛股2023-2-7 9:01:05
·【读财报】1月重要股东增减持动态：医药生物行业增减持金额均居首位2023-2-7 8:11:48
·1月重要股东增减持动态：医药生物行业增减持金额均居首位2023-2-7 8:11:42

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]